Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, et al. (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397(10285):1637–1645. https://doi.org/10.1016/s0140-6736(21)00676-0

Article  CAS  Google Scholar 

Adegunsoye A, Bachman WM, Flaherty KR, Li Z, Gupta S (2024) Use of race-specific equations in pulmonary function tests impedes potential eligibility for care and treatment of pulmonary fibrosis. Ann Am Thorac Soc 21(8):1156–1165. https://doi.org/10.1513/AnnalsATS.202309-797OC

Article  PubMed  PubMed Central  Google Scholar 

Allen RJ, Guillen-Guio B, Croot E, Kraven LM, Moss S, Stewart I et al (2022) Genetic overlap between idiopathic pulmonary fibrosis and COVID-19. Eur Respir J. https://doi.org/10.1183/13993003.03132-2021

Article  PubMed  PubMed Central  Google Scholar 

Ball L, Barisione E, Mastracci L, Campora M, Costa D, Robba C et al (2021) Extension of collagen deposition in COVID-19 post mortem lung samples and computed tomography analysis findings. Int J Mol Sci. https://doi.org/10.3390/ijms22147498

Article  PubMed  PubMed Central  Google Scholar 

Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM (2022) Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400(10350):452–461. https://doi.org/10.1016/s0140-6736(22)01214-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Belkin S, Benthien J, Axt PN, Mohr T, Mortensen K, Weckmann M et al (2023) Impact of heated tobacco products, e-cigarettes, and cigarettes on inflammation and endothelial dysfunction. Int J Mol Sci. https://doi.org/10.3390/ijms24119432

Article  PubMed  PubMed Central  Google Scholar 

Bernard I, Limonta D, Mahal LK, Hobman TC (2020) Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses. https://doi.org/10.3390/v13010029

Article  PubMed  PubMed Central  Google Scholar 

Bharat A, Machuca TN, Querrey M, Kurihara C, Garza-Castillon R Jr, Kim S et al (2021) Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med 9(5):487–497. https://doi.org/10.1016/s2213-2600(21)00077-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW et al (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 21(5):319–329. https://doi.org/10.1038/s41577-021-00536-9

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R et al (2021) Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep 11(1):4863. https://doi.org/10.1038/s41598-021-83831-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chilosi M, Poletti V, Ravaglia C, Rossi G, Dubini A, Piciucchi S et al (2021) The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime. Mod Pathol 34(8):1444–1455. https://doi.org/10.1038/s41379-021-00808-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cho JG, Lee A, Chang W, Lee MS, Kim J (2018) Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol 9:294. https://doi.org/10.3389/fimmu.2018.00294

Article  PubMed  PubMed Central  CAS  Google Scholar 

Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D et al (2020) SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 183(4):729–737. https://doi.org/10.1111/bjd.19327

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cucina A, Corvino V, Sapienza P, Borrelli V, Lucarelli M, Scarpa S et al (1999) Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem Biophys Res Commun 257(2):306–312. https://doi.org/10.1006/bbrc.1999.0478

Article  PubMed  CAS  Google Scholar 

Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133–146. https://doi.org/10.1038/s41579-022-00846-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Rooij L, Becker LM, Teuwen LA, Boeckx B, Jansen S, Feys S et al (2023) The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution. Cardiovasc Res 119(2):520–535. https://doi.org/10.1093/cvr/cvac139

Article  PubMed  CAS  Google Scholar 

de Roquetaillade C, Bredin S, Lascarrou JB, Soumagne T, Cojocaru M, Chousterman BG et al (2021) Timing and causes of death in severe COVID-19 patients. Crit Care 25(1):224. https://doi.org/10.1186/s13054-021-03639-w

Article  PubMed  PubMed Central  Google Scholar 

Dejana E, Hirschi KK, Simons M (2017) The molecular basis of endothelial cell plasticity. Nat Commun 8:14361. https://doi.org/10.1038/ncomms14361

Article  PubMed  PubMed Central  CAS  Google Scholar 

Deng G, Zhang L, Wang C, Wang S, Xu J, Dong J et al (2020) AGES-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-β1 and BMPR2 signaling. Exp Gerontol 141:111088. https://doi.org/10.1016/j.exger.2020.111088

Article  PubMed  CAS  Google Scholar 

Donato A, EskurzaSilver JI et al (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor- B. Circulation Res 100(11):1659–1666

Article  PubMed  CAS  Google Scholar 

Eapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A et al (2020) Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. https://doi.org/10.1183/13993003.03167-2020

Article  PubMed  PubMed Central  Google Scholar 

Fadista J, Kraven LM, Karjalainen J, Andrews SJ, Geller F, Baillie JK et al (2021) Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. EBioMedicine 65:103277. https://doi.org/10.1016/j.ebiom.2021.103277

Article  PubMed  PubMed Central  CAS  Google Scholar 

Falleni M, Tosi D, Savi F, Chiumello D, Bulfamante G (2021) Endothelial-mesenchymal transition in COVID-19 lung lesions. Pathol Res Pract 221:153419. https://doi.org/10.1016/j.prp.2021.153419

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferraro V, Morisset J (2025) Influence of race and ethnicity on the precision diagnosis and treatment of ILD. In: B. F. Collins, & S. B. Montesi (Eds.), Precision Medicine in Interstitial Lung Disease (pp. 121–142). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-87183-2_7.

Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718–1727. https://doi.org/10.1056/NEJMoa1908681

Article  PubMed  CAS  Google Scholar 

Fleenor BS, Marshall KD, Rippe C, Seals DR (2011) Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: potential role of inflammation. J Vasc Res 49(1):59–64

Article  PubMed  PubMed Central  Google Scholar 

Gaikwad AV, Eapen MS, McAlinden KD, Chia C, Larby J, Myers S et al (2020) Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis. Exp Rev Respir Med 14(10):1027–1043. https://doi.org/10.1080/17476348.2020.1795832

Article  CAS